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Abstract:
Background: In literature there are only a few descriptions of the typical presentation of solitary fibrous tumours (SFT) 
and only a few case reports showing its unusual clinical and radiological features.
Methods: We retrospectively evaluated the computed tomography scans of 36 patients presenting with a histological 
diagnosis of SFT between 1998 and 2008. 
Results: We present five cases of SFT with an atypical clinical presentation and radiological features.
Conclusions: SFT can occasionally present with unusual radiological features making a differential diagnosis difficult. 
Even thought imaging plays a fundamental role in the initial diagnostic approach, final diagnosis in only confirmed by 
biopsy and histology. Hippokratia. 2012; 16 (3): 269-274
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Solitary Fibrous Tumours of the Pleura (SFTP), have 
been described by a variety of terms such as benign mes-
othelioma, localized mesothelioma, and subpleural mes-
othelioma1-3, reflecting the controversy over these tumors. 
It is a rare tumour with a prevalence of 2,8 per 100.000 
cases (less than 5% of growing pleural masses)2. 
Usually SFTP arise within the pleural cavity with 
most cases originating from the visceral pleura4-6. The 
latter are larger than those originating from the parietal 
pleura. SFTP originating from the pleura need to be dis-
tinguished from mesotheliomas. The differential diag-
nosis between these two tumours is important because 
SFTP is usually a benign tumour with a good prognosis 
whereas on the other hand, mesothelioma is typically an 
aggressive tumour with a poor prognosis. The majority 
of SFTP are benign (80%) however rare cases of malig-
nancy have been reported in literature2,4.
Mesothelioma cells originate from the mesothelial 
pleural cells. As some authors have previously described 
SFTP cells originate from the myofibrillary mesenchy-
mal cells located in the submesothelial connective tissue1, 
suggested by the histological and immuno-histochemical 
features7 (for example SFTP is CD34 positive8 as op-
posed to mesothelioma which is CD34 negative).
In rare cases this type of tumour does not originate 
from the pleura but rather from other sites within the 
thorax9-12. In these cases the Solitary Fibrous Tumour 
(SFT) needs to be distinguished from other pathologies 
such as neurogenic tumours, thymic tumours, teratoma, 
germ cells tumour, lipomas, sarcoma and epithelioid 
hemangioendothelioma1,4,7,11-14. An extrathoracic presen-
tation of the SFT is extremely rare1,7,15-19.
Usually SFTP is discovered incidentally as a single 
intra-thoracic mass discovered on chest X-Ray requested 
for other reasons1,4,5.
The majority of patients affected by this disease are 
asymptomatic. Symptomatic patients may present with 
cough, chest pain and dyspnea, while hemoptysis and ob-
structive pneumonitis are rare presentations1-4. Patients with 
tumour localized on the diaphragmatic pleura can present 
with vague complaints localized in the right hypochondrium; 
occasionally SFTP can also present with a paraneoplastic 
syndrome (digital clubbing, hypertrophic osteoarthropathy 
and refractory hypoglycemia), even though this is rare1,2,5,20. 
The aim of this article is to present a case series of 
SFT having an atypical clinical presentation and radio-
logical findings.
The aim of this report is to make the radiologist aware 
of the possible diagnosis of SFT when these have atypical 
clinical and radiological presentations.
Materials and Methods 
We retrospectively evaluated the computed tomogra-
phy (CT) scans of 36 patients from our pathological ar-
chive who presented with a histological diagnosis of SFT 
between 1998 and 2008. 
CASE SERIES
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Figure 1: Case 1 - Axial CT scan of a 68 year-old woman 
showing a bulky mass in the left lower lobe with an inhomo-
geneous density after contrast medium administration (140 
H.U)
Figure 2: Case 1 - Axial CT scans of the renal mass showing the pre and post contrast behaviour of the renal lesion (SFT) 
mimicking renal cell carcinoma: 
A) pre-contrast phase: mild hyperdensity (55 H.U).
B) arterial phase: rapid progressive uptake.
C) portal phase: reaching maximal uptake (158 H.U).
D) equilibrium phase with a complete contrast medium wash-out. 
We selected 5 out of the 36 cases, showing an atypical 
radiological and clinical presentation, all of whom had a 
complete radiological staging performed by CT scan (GE 
Lightspeed 16 slice CT scanner General Electric Health-
care; Milwaukee, WI).
In 4 out of 5 patients a PET/CT scan was performed, 
and in 1 out of 5 an additional ultrasound examination.
The histological diagnosis was based on the England 
criteria21.
Case 1
A 68 year old woman who presented due to refractory 
cough underwent chest x-ray and CT scan.
The chest X-ray showed a bulky 6 cm mass in the left 
lower lobe, originating from the pleural sheets and show-
ing expansive behaviour.
The CT scan confirmed the presence of the mass with 
an inhomogeneous density after contrast medium admin-
istration (140 H.U) without infiltration of the surrounding 
tissues and no lymphadenopathy (figure 1). As a collateral 
finding an expansive mass of 2.5 cm was identified between 
the spleen and the left kidney (figure 2). This was further 
studied with an abdominal CT scan which showed a mild 
hyperdensity (55 H.U) on the basal CT scan, with progres-
sive contrast enhancement after contrast medium, reaching 
a value of 158 H.U. in the portal venous phase and complete 
contrast medium wash out at equilibrium (figure 2).
An 18FDG PET/CT scan showed uptake at the level of 
the thoracic mass (SUV max of 6.04), however no uptake 
was seen in the abdominal mass.
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Figure 3: Case 2 - Axial CT scan of a 35 year old man showing two solid well defined masses in the mediastinum:
 a) inhomogeneous contrast enhancement with hypodense areas with miliary calcified spots (Thymoma).
 b) inhomogeneous contrast enhancement mass with hypodense areas without calcifications (SFT).
Figure 4:Case 3 - Axial CT scan of a 67 year old woman 
showing two masses both with oval shape and well defined 
margins with an expansive pattern of growth. The difference 
in contrast enhancement behaviour is due to the lipid con-
tent of the left mass (neuroma) which is richer in lipid con-
tent than SFTP. 
In order to characterize the lesions we performed bi-
opsies of the two masses.
For the lung mass we performed a CT-guided biopsy 
using a semi-automatic Gallini needle (18G) whereas for 
the left hypocondrial mass we performed an ultrasound 
guided biopsy using an automatic needle (18G). Both 
masses were confirmed to be a benign SFT at histology.
Following a multidisciplinary team meeting the de-
cision was to surgically remove the thoracic lesion and 
perform regular follow-up of the abdominal mass.
After 4 years of follow-up the abdominal mass re-
mains identical in both size and density at CT. 
Case 2
A 35 year old male patient presented to our attention 
with a six week history of asthenia and diffuse itching not 
responsive to pharmacological therapy.
A chest X-Ray showed bulging of the mediastinal 
borders, confirmed by thoracic CT. CT also showed two 
solid well defined masses in the mediastinum: one in the 
right paracardiac area and another left sided mass just an-
terior to the aortic arch.
Both mediastinal masses showed an inhomogeneous 
contrast enhancement with hypodense areas. The left sid-
ed mass showed miliary calcified spots (figure 3).
The patient underwent surgery to remove both masses 
with a final histopathologic diagnosis of :
- thymoma type B2 according to the WHO classifica-
tion for the left sided mass,
- benign SFT with an intrathymic origin for the right 
sided mass.
The patient was diagnosed with myasthenia gravis 
a few months after surgery. The patient performed an 
annual follow-up CT and remains disease-free during a 
follow-up period of 4 years.
Case 3
A 67 year old woman had a surgical excision of the 
5th and 6th left rib at another institution with a histologi-
cal diagnosis of a lipoma-like sarcoma.
During the pre-surgical radiological assessment the 
CT scan demonstrated two other masses in the thorax.
One was identified between the IIIrd and IVth inter-
costal space, of probable pleural origin showing ovular 
morphology, and well defined margins with an expansive 
pattern of growth. The other mass showing similar mor-
phology was located in the posterior mediastinum behind 
the trachea. Both masses showed homogeneous contrast 
enhancement, however this was greater for the right sided 
lesion (figure 4).
CT-guided biopsies of the lesions with a semi-auto-
matic Gallini needle (18G) were non-diagnostic of dis-
ease. A PET/CT scan did not show significant areas of 
pathological uptake. Two further surgical biopsies per-
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Figure 6: Case 5 - Axial CT scan of a 60 year old woman 
showing an entirely intrapulmonary solitary fibrous tumour 
with round shape and well defined margins. These could be 
typical features of a pulmonary metastasis, and therefore 
could potentially be a pitfall.
Figure 5: Case 4 - Axial CT scan of a 47 year old woman showing the progressive growth pattern typical of malignant lesions: 
two retroperitoneal masses with markedly inhomogeneous contrast medium uptake (A) as shown in the two pleural masses 
(B).
formed at different sittings revealed a benign SFTP for 
the right sided lesion and a Schwannoma for the left sided 
lesion.
The next two surgical approaches to the lesions, per-
formed in different sessions gave two different diagnosis: 
benign SFTP for the right sided mass and a Schwannoma 
for the left sided mass. 
Case 4
A 47 year old woman presented with a history of ma-
lignant Fibrous Tumours of the Pleura (FTP) of the left 
diaphragm; she had previously undergone several surgi-
cal procedures to remove several intrathoracic masses. 
The patient came to our attention afer years later with 
multiple bilateral lung recurrences.
Baseline staging of the disease was performed using 
CT and PET scan. 
The first CT scan performed at our Institute demon-
strated distinct signs of tumour liquification with an inho-
mogeneous contrast enhancement, with hypodense areas 
correlating with areas of lower 18FDG uptake within the 
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lesions. 
Follow-up examinations with CT and PET/CT 
showed disease relapse with several new lung metasta-
sis. These were then treated with multiple surgical proce-
dures as well as thermoablation and radiotherapy in view 
of the reduced Total Lung Capacity following several 
pulmonary procedures. A follow-up CT scan of the tho-
rax, showed disease progression with pleuro-pulmonary 
metastases. A PET/CT detected homogenously increased 
18FDG uptake in the major tumour areas in the thorax and 
abdominal cavity which were consequently treated with 
chemotherapy. Several months later, a new relapse was 
diagnosed in both abdomen and thorax (figure 5).
Case 5
A 60 year old woman, performing a routine follow-
up chest X-ray for a previous ductal breast carcinoma, 
was seen to have a radiopaque rounded lesion in the left 
pulmonary apex. This was  further studied performing a 
thoracic CT scan and PET/CT.
Both techniques confirmed the suspicious secondary 
nature of the lesion:
At CT scan examination the nodule had a homoge-
neous contrast enhancement, well defined margins situ-
ated in the central parenchyma with no connections to the 
pleura or mediastinum (figure 6).
PET/CT showed an intermediate uptake of 18FDG. 
Considering the oncological history of the patient, and 
radiological characteristics of the lesion could be attributed 
to metastases, a wedge surgical excision of the single lesion 
was performed. The histological diagnosis was an intrapa-
renchymal SFT with a benign pattern. Considering the be-
nign nature of the lesion an annual thoracic CT scan was 
scheduled with no evidence of disease relapse after 4 years.
Discussion 
In literature there are only a few studies on SFT. Our 
aim was to present radiological features of some selected 
cases of this rare disease. 
All the radiological features, particularly those seen 
on CT, showed the typical morphological aspects of an 
expansive mass (round shape and well defined margins), 
with an increased contrast enhancement, and an increas-
ingly inhomogeneous enhancement directly proportional 
to the size of lesions (due to central necrosis, haemor-
rhage and cystic changes with a patchy pattern)2,15,20,23. 
There were no obvious pathognomonic signs of SFT1,24.
The gold standard for final diagnosis of SFT remains 
the surgical approach. In literature there are many papers 
describing SFT as a prevalently benign lesion1,2,4,5 but few 
papers report a malignant type of SFTP with local and 
distant metastasis15.
In cases 1 and 4 we showed how SFT presented with 
distant metastasis; a typical sign of malignancy. For ex-
ample in case 1 we present a patient with a single pulmo-
nary and a synchronous renal lesion thought to be two 
primary lesions due to the radiological features. This 
could potentially lead to a difficult diagnosis as the re-
nal mass may mimic a renal cell carcinoma25,26. There are 
rare cases of primary renal SFT.
Case 4 was a malignant FTP with multiple relaps-
ing metastasis in the abdomen diagnosed at surgery. 
These lesions were not responsive to therapy (surgery, 
radiofrequency and chemotherapy). SFTP, as reported in 
literature1,2,4,5, originates from the parietal pleura when the 
lesions are larger in size. On the other hand the smaller 
SFTP originate from the visceral pleura.
Case 2 describes a patient with myasthenia gravis with 
2 separate masses originating from the mediastinal pleura 
consising of thymic tissue. The presence of myasthenia 
gravis relates to the presence of the thymoma; additionally 
one of these two masses also presented an intrinsic SFT. 
This example showed that SFT can potentially present 
within the mediastinal pleura12. There are no standard fea-
tures to differentiate an SFT from a thymoma27; in this case 
we can’t consider the presence of intrinsic calcifications a 
radiological sign of an SFTP as described in literature1,2,24 
(the intrathymic SFT did not show intrinsic calcifications 
as opposed to the contralateral mass). When considering 
only the radiological features (such as calcifications) one 
could be lead into making an erroneous diagnosis. 
In case 3 we demonstrate how the differential diag-
nosis of SFTP can also include neuroma. CT features can 
be helpful to differentiate these two pathologies. In par-
ticular the neuroma is richer in lipid content compared to 
SFTP, and is more likely to be hypodense. This could also 
explain the differences in contrast enhancement.
In case 5 we showed a rare case of SFT which did 
not originate from the pleura but originated in central 
lung parenchyma11,28. The imaging characteristics (new, 
single lesion, round shape and well defined margins) and 
the positive uptake of 18FDG of the mass made it highly 
suspicious for a breast cancer metastasis due to the clini-
cal history of the patient (previous surgery for invasive 
ductal breast carcinoma).
When encountering such cases we suggest consid-
ering the possibility of an fibrous tumour, because even 
though it is rare, the prognosis and treatment changes 
significantly. According to the limited literature available 
there is no evidence of malignancy for whole intrapul-
monary solitary fibrous tumours, however owing to the 
limited experience follow-up must be performed4,11.
In conclusion in this case series we presented a 
number of selected cases with an atypical clinical and 
radiological presentation. Imaging techniques are still 
the first fundamental tools to obtain an initial diagnosis 
based on the morphological and functional features of the 
fibrous tumour but the final diagnosis still remains the 
interventional approach.
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